These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22154240)

  • 1. Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience.
    Onitilo AA; Doi SA; Engel JM; Glurich I; Johnson J; Berg R
    Thromb Res; 2012 Jul; 130(1):27-31. PubMed ID: 22154240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review.
    Deitcher SR; Gomes MP
    Cancer; 2004 Aug; 101(3):439-49. PubMed ID: 15274057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study.
    Kovac M; Kovac Z; Tomasevic Z; Vucicevic S; Djordjevic V; Pruner I; Radojkovic D
    Eur J Intern Med; 2015 Jan; 26(1):63-7. PubMed ID: 25592075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen and risk of idiopathic venous thromboembolism.
    Meier CR; Jick H
    Br J Clin Pharmacol; 1998 Jun; 45(6):608-12. PubMed ID: 9663819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors.
    Xu X; Chlebowski RT; Shi J; Barac A; Haque R
    Breast Cancer Res Treat; 2019 Apr; 174(3):785-794. PubMed ID: 30659431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States.
    Faiz AS; Guo S; Kaveney A; Philipp CS
    Blood Coagul Fibrinolysis; 2021 Sep; 32(6):373-381. PubMed ID: 33973894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study.
    Hernandez RK; Sørensen HT; Pedersen L; Jacobsen J; Lash TL
    Cancer; 2009 Oct; 115(19):4442-9. PubMed ID: 19569248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
    J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association.
    Glurich I; Chyou PH; Engel JM; Cross DS; Onitilo AA
    Clin Med Res; 2013 Feb; 11(1):16-25. PubMed ID: 23411630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen.
    Chen TW; Chen HM; Lin CH; Huang CS; Cheng AL; Lai MS; Lu YS
    Breast Cancer Res Treat; 2014 Nov; 148(1):135-42. PubMed ID: 25240736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
    Decensi A; Maisonneuve P; Rotmensz N; Bettega D; Costa A; Sacchini V; Salvioni A; Travaglini R; Oliviero P; D'Aiuto G; Gulisano M; Gucciardo G; del Turco MR; Pizzichetta MA; Conforti S; Bonanni B; Boyle P; Veronesi U;
    Circulation; 2005 Feb; 111(5):650-6. PubMed ID: 15699284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.
    Duggan C; Marriott K; Edwards R; Cuzick J
    J Clin Oncol; 2003 Oct; 21(19):3588-93. PubMed ID: 14512389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.
    Walker AJ; West J; Card TR; Crooks C; Kirwan CC; Grainge MJ
    Blood; 2016 Feb; 127(7):849-57; quiz 953. PubMed ID: 26574606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Factor V Leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen.
    Onitilo AA; Doi SA; Engel JM; Glurich I; Berg R
    Thromb Res; 2013 Jun; 131(6):567-8. PubMed ID: 23497923
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.
    Amir E; Seruga B; Niraula S; Carlsson L; Ocaña A
    J Natl Cancer Inst; 2011 Sep; 103(17):1299-309. PubMed ID: 21743022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism.
    Klil-Drori AJ; Yin H; Tagalakis V; Aprikian A; Azoulay L
    Eur Urol; 2016 Jul; 70(1):56-61. PubMed ID: 26138040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen-associated thromboembolism in breast cancer.
    Eroglu A
    Thromb Res; 2013 Jun; 131(6):566. PubMed ID: 22959707
    [No Abstract]   [Full Text] [Related]  

  • 18. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal therapy for breast cancer and diabetes incidence among postmenopausal women.
    Santorelli ML; Hirshfield KM; Steinberg MB; Rhoads GG; Lin Y; Demissie K
    Ann Epidemiol; 2016 Jun; 26(6):436-40. PubMed ID: 27157863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
    Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
    Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.